Status:
COMPLETED
Role of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Children With Myocarditis
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Myocarditis
Eligibility:
All Genders
1-18 years
Brief Summary
Children can have or develop certain problems with their heart function, specifically with the heart muscle or myocardium. This problem can be caused by many things specifically by infection resulting...
Detailed Description
All children who present with signs and symptoms of myocarditis and have laboratory findings consistent with cardiomyopathy will be eligible. After prospective consent, all subjects will receive: (1) ...
Eligibility Criteria
Inclusion
- 1\. Evidence from diagnostic tests and physical exam that confirm inflammatory cardiomyopathy.
Exclusion
- Patients with structural heart disease other than septal defects or patent ductus arteriosus
- Patients with history of arrhythmia
- Patients with history of ventricular dysfunction diagnosed by echocardiograms
- Patients with history of chronic systemic illness
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00693134
Start Date
March 1 2004
End Date
July 1 2006
Last Update
June 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Medical Center
Dallas, Texas, United States, 75235